New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 30, 2014
10:13 EDTALK, TYL, TECD, SDRL, RY, SOL, PRXL, OVTI, BLOX, HSH, HHS, GMK, FRED, EXAS, VWDRYOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Alaska Air (ALK) downgraded to Hold from Buy at Stifel... Exact Sciences (EXAS) downgraded to Neutral from Outperform at Wedbush... Fred's (FRED) downgraded at BB&T... Gruma (GMK) downgraded to Hold from Buy at Deutsche Bank... Harte-Hanks (HHS) downgraded at BMO Capital... Hillshire Brands (HSH) downgraded to Market Perform from Outperform at Bernstein... Infoblox (BLOX) downgraded to Sector Perform from Outperform at Pacific Crest... OmniVision (OVTI) downgraded to Underperform from Market Perform at Raymond James... PAREXEL (PRXL) assumed with a Market Perform at Raymond James... ReneSola (SOL) downgraded to Neutral from Buy at Roth Capital... Royal Bank of Canada (RY) downgraded to Sector Performer from Outperformer at CIBC... Seadrill (SDRL) downgraded to Sell from Hold at Nordea... Tech Data (TECD) downgraded to Underperform from Outperform at CLSA... Tyler Technologies (TYL) downgraded to Hold from Buy at Dougherty... Vestas Wind (VWDRY) downgraded to Neutral from Buy at Goldman.
News For ALK;EXAS;FRED;GMK;HHS;HSH;BLOX;OVTI;PRXL;SOL;RY;SDRL;TECD;TYL;VWDRY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 15, 2014
07:09 EDTSDRLSeadrill initiated with a Buy at ISI Group
Subscribe for More Information
05:27 EDTVWDRYVestas Wind upgraded to Neutral from Underperform at Exane BNP Paribas
Subscribe for More Information
05:25 EDTVWDRYVestas Wind upgraded to Neutral from Underperform at Credit Suisse
Subscribe for More Information
October 14, 2014
11:17 EDTEXASOptions with decreasing implied volatility
Subscribe for More Information
October 13, 2014
12:01 EDTEXASOptions with decreasing implied volatility
Options with decreasing implied volatility: EXAS INFY YUM FDO HSY
07:31 EDTEXASExact Sciences price target raised to $42 from $25 at Benchmark Co.
Benchmark Co. raised its price target for Exact Sciences shares to $42 citing the Medicare coverage decision and reimbursement rate of $502 for the company's test. The firm had previously modeled a price of $300 for Cologuard. It reiterates a Buy rating on the name.
06:06 EDTRYRoyal Bank of Canada ordered to pay $75.8M in Rural/Metro suit
Subscribe for More Information
October 12, 2014
15:36 EDTRYRoyal Bank of Canada ordered to pay $75.7M in Rural/Metro suit, Bloomberg says
Subscribe for More Information
October 10, 2014
16:22 EDTEXASOn The Fly: Closing Wrap
Stocks on Wall Street had a bit of a see-saw trading day, but ended the session in the red once again. The Nasdaq took the brunt of the losses, falling over 2%, while the Dow's slide erased its gains for the year. ECONOMIC EVENTS: In the U.S., the import price index fell 0.5% in September, versus expectations for a 0.7% decline. Oil slumped to a four-year low during the session, as brent crude touched $88.11 intra-day, its lowest level since December 2010. COMPANY NEWS: The semiconductor sector was weak across the board after one of the companies in the space, Microchip Technology (MCHP), warned that it believes the sector has entered a correction. Microchip President and CEO Steve Sanghi claimed his company often sees the turn of the semiconductor industry ahead of others, noting that it does business with over 80,000 customers and that it built a significant amount of inventory in the distribution channel in the September quarter. Sanghi stated, "We believe that another industry correction has begun and that this correction will be seen more broadly across the industry in the near future. Microchip, which also pre-announced weaker than expected second quarter revenue, dropped $5.58, or 12.26%, to $39.96. Intel (INTC) fell $1.71, or 5.09%, to $31.91, Avago (AVGO) declined $9.24, or 11.46%, to $71.36, Texas Instruments (TXN) slipped $3.28, or 7.13%, to $42.74 and Micron (MU) dropped $2.71, or 8.86%, to $27.93. MAJOR MOVERS: Among the notable gainers was Exact Sciences (EXAS), which rallied $6.48, or 35.76%, to $24.60 after the company announced last night that the Centers for Medicare & Medicaid Services, or CMS, had agreed to cover the company's colorectal cancer and pre-cancer test through Medicare. Also higher was Dave & Buster (PLAY), which gained $1.28 to $17.28 after commencing trading on the Nasdaq following its initial public offering. Among the noteworthy losers was Procera Networks (PKT), which was downgraded by at least four research firms and plunged $2.85, or 33.33%, to $5.70 after the company warned its Q3 revenue will miss expectations. Also lower were shares of Caesars (CZR), which dropped $1.92, or 17.36%, to $9.14 after disclosing in a regulatory filing that its Chief Accounting Officer resigned to accept a position with another company. INDEXES: The Dow fell 115.15, or 0.69%, to 16,544.10, the Nasdaq plunged 102.10, or 2.33%, to 4,276.24, and the S&P 500 dropped 22.08, or 1.15%, to 1,906.13.
13:08 EDTEXASOn The Fly: Midday Wrap
Stocks on Wall Street opened in negative territory and saw several swings throughout the morning. Near midday the averages were mixed, with the Dow a bit higher and the Nasdaq weighed down by weakness across the semiconductor sector. ECONOMIC EVENTS: In the U.S., the import price index fell 0.5% in September, versus expectations for a 0.7% decline. COMPANY NEWS: Shares of a number of semiconductor makers, including industry giant Intel (INTC), were sharply lower after one of the companies in the space, Microchip Technology (MCHP), warned that it believes the sector has entered a correction. Microchip President and CEO Steve Sanghi claimed his company often sees the turn of the semiconductor industry ahead of others, noting that it does business with over 80,000 customers and that it built a significant amount of inventory in the distribution channel in the September quarter. Sanghi stated, "We believe that another industry correction has begun and that this correction will be seen more broadly across the industry in the near future. Near noon, Microchip dropped 11%, Intel fell almost 4%, Texas Instruments (TXN) slipped over 6%, Micron (MU) dropped 6% and Fairchild (FCS) declined 12%. MAJOR MOVERS: Among the notable gainers was Exact Sciences (EXAS), which rallied 35% after the company announced last night that the Centers for Medicare & Medicaid Services, or CMS, had agreed to cover the company's colorectal cancer and pre-cancer test through Medicare. Among the noteworthy losers were a number of companies that, similarly to Microchip, warned that their quarterly results will likely miss expectations, including Procera Networks (PKT), which plunged 34%, Manitowoc (MTW), which fell 9%, and Sizmek (SZMK), which dropped 21%. INDEXES: Near midday, the Dow was up 38.02, or 0.23%, to 16,697.27, the Nasdaq was down 35.89, or 0.82%, to 4,342.45, and the S&P 500 was up 0.42, or 0.02%, to 1,928.63.
11:18 EDTEXASOptions with decreasing implied volatility
Subscribe for More Information
11:05 EDTEXASExact Sciences jumps after CMS agrees to cover cancer test
Subscribe for More Information
10:01 EDTPRXLOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:00 EDTEXASOn The Fly: Pre-market Movers
Subscribe for More Information
07:57 EDTPRXLPAREXEL downgraded at ISI Group
Subscribe for More Information
07:50 EDTEXASExact Sciences to see significant short squeeze on CMS decision, says Canaccord
Subscribe for More Information
07:32 EDTEXASExact Sciences price target raised to $27 from $20 at Jefferies
Subscribe for More Information
07:16 EDTEXASExact Sciences CMS decision a 'major positive' for shares, says Mizuho
Subscribe for More Information
07:12 EDTEXASExact Sciences price target raised to $34 from $28 at JMP Securities
JMP Securities increased its price target on Exact Sciences after CMS stated that the company's colorectal screening tool would be covered by Medicare and granted the company's request to price the test at $502. The firm thinks Cologuard will become the standard of care for the detection of colorectal cancer. It reiterates an Outperform rating on the stock. .
06:18 EDTPRXLPAREXEL downgraded to Neutral from Buy at ISI Group
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use